Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz
Right arrow CME: Take the course for this article:
Volume 71, Number 8, August 19, 2008
Right arrow Data Supplement
Right arrow Podcast
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Bell, G. S.
Right arrow Articles by Sander, J. W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bell, G. S.
Right arrow Articles by Sander, J. W.
Related Collections
Right arrow All Epilepsy/Seizures
NEUROLOGY 2008;71:578-582
© 2008 American Academy of Neurology

Drowning in people with epilepsy

How great is the risk?

G. S. Bell, MD, A. Gaitatzis, MD, C. L. Bell, A. L. Johnson, PhD and J. W. Sander, PhD, FRCP

From the Department of Clinical & Experimental Epilepsy (G.S.B., A.G., J.W.S.), UCL Institute of Neurology, and National Hospital for Neurology and Neurosurgery, UCL Hospitals NHS Foundation Trust, Queen Square, London; Bristol Medical School (C.L.B.); MRC Biostatistics Unit (A.L.J.), Institute of Public Health, University Forvie Site, Cambridge, UK; and SEIN–Epilepsy Institutes of the Netherlands Foundation (J.W.S.), The Netherlands.

Address correspondence and reprint requests to Prof. Ley Sander, Box 29, Department of Clinical & Experimental Epilepsy, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK lsander{at}ion.ucl.ac.uk

Background: People with epilepsy are known to be at increased risk of death by drowning but there are few data available regarding the size of the risk. We aimed to quantify the risk using meta-analysis.

Methods: A literature search identified 51 cohorts of people with epilepsy in whom the number of deaths by drowning in people with epilepsy and the number of person-years at risk could be estimated. Population data were taken from the WHO Statistical Information Service or from the UK Office for National Statistics where available. Standardized mortality ratios (SMRs) with 95% CIs were calculated for each cohort, for groups of cohorts, and for the total population. Additionally, an SMR for drowning in people with epilepsy in England and Wales (1999–2000) was calculated using National Registries.

Results: Eighty-eight drowning deaths were observed compared with 4.70 expected, giving an SMR of 18.7 (95% CI 15.0 to 23.1). Compared with community-based incident studies (SMR 5.4), the SMR was significantly raised in prevalent epilepsy (SMR 18.0), in people with epilepsy and learning disability (SMR 25.7), in those in institutional care (SMR 96.9), and in those who had a temporal lobe excision (SMR 41.1). The SMR for people with epilepsy in England and Wales was 15.3.

Conclusion: The risk of drowning in people with epilepsy is raised 15- to 19-fold compared with people in the general population. It is important that people with epilepsy and their carers be informed of these risks so that deaths can be prevented.

Abbreviations: PYFU = person-years of follow-up; SMR = standardized mortality ratio; SUDEP = sudden unexpected death in epilepsy.


Supplemental data at www.neurology.org

Supported by the UK National Society for Epilepsy and by UCLH/UCL, who received a proportion of funding from the Department of Health’s NIHR Biomedical Research Centres funding scheme.

Disclosure: J.W.S. has received honoraria, consultancy fees, grants, and travel grants from various pharmaceutical companies including Novartis, Pfizer, UCB, Eisai, Schwarz Pharma, Janssen-Cilag, Sanofi-Aventis, and GSK. The National Society for Epilepsy endows his current position. He has been a member of the Management Committee of the International League against Epilepsy and the Executive Committee of the International Bureau for Epilepsy. He is currently a Council member of the British chapter of the International League against Epilepsy and of the charity Epilepsy Action.

Received November 20, 2007. Accepted in final form May 20, 2008.




This article has been cited by other articles:


Home page
JWatch NeurologyHome page
Epilepsy and Risk for Drowning
Journal Watch Neurology, December 30, 2008; 2008(1230): 3 - 3.
[Full Text]


Home page
JWatch PediatricsHome page
Drowning Is an Important Cause of Death in People with Epilepsy
Journal Watch Pediatrics and Adolescent Medicine, September 17, 2008; 2008(917): 2 - 2.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by AAN Enterprises, Inc.